Correlation Between Processa Pharmaceuticals and Biotron

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Biotron Limited, you can compare the effects of market volatilities on Processa Pharmaceuticals and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Biotron.

Diversification Opportunities for Processa Pharmaceuticals and Biotron

0.26

Correlation Coefficient

Processa Pharmaceuticals  Biotron

Modest diversification

The 3 months correlation between Processa and Biotron is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Biotron go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Biotron

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 1.7 times more return on investment than Biotron. However, Processa Pharmaceuticals is 1.7 times more volatile than Biotron Limited. It trades about 0.0 of its potential returns per unit of risk. Biotron Limited is currently generating about -0.16 per unit of risk. If you would invest  111.00  in Processa Pharmaceuticals on September 5, 2024 and sell it today you would lose (4.00) from holding Processa Pharmaceuticals or give up 3.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Biotron Limited

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Biotron Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotron Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Processa Pharmaceuticals and Biotron

The main advantage of trading using opposite Processa Pharmaceuticals and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.

The idea behind Processa Pharmaceuticals and Biotron Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.